RP
LFCR icon

Riverwater Partners’s Lifecore Biomedical LFCR Stock Holding History

Riverwater Partners’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20,616
Closed -$134K – 205
2022
Q4 		$134K Buy
20,616
+78
+0.4% +$643 0.11% 195
2022
Q3 		$183K Sell
20,538
-12,349
-38% -$126K 0.18% 179
2022
Q2 		$328K Buy
32,887
+220
+0.7% +$2.18K 0.33% 106
2022
Q1 		$378K Hold
32,667
– – 0.62% 71
2021
Q4 		$363K Buy
+32,667
New +$317K 0.32% 112

Other funds holding LFCR

GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

Riverwater Partners's LFCR Position: Q1 2023 in Review

Riverwater Partners sold out of Lifecore Biomedical (LFCR) in Q1 2023, closing a stake of 20,616 shares — an estimated $134K sold.

Riverwater Partners first reported a position in LFCR in Q4 2021 and held it in 5 quarters. The position peaked at $378K in Q1 2022. 82 funds tracked by Wall St. Rank hold LFCR as of Q1 2023.

  • Riverwater Partners reported no remaining Lifecore Biomedical position as of Q1 2023 after selling out during the quarter.
  • Riverwater Partners sold 20,616 Lifecore Biomedical shares in Q1 2023, an estimated $134K.
  • Riverwater Partners first reported a position in Lifecore Biomedical in Q4 2021 and held it in 5 quarters.
  • Riverwater Partners's Lifecore Biomedical position peaked at $378K in Q1 2022.
  • 82 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2023.

Based on Riverwater Partners's 13F filing for Q1 2023, filed 12 Apr 2023.